Companies: 10,795·Total market cap: $144.5T
Integra LifeSciences Holdings Corporation

Integra LifeSciences Holdings Corporation

IARTNASDAQHealthcare● Active
$17.04
+$0.05(+0.29%)
Market Cap$1.3B
P/E Ratio
52W High$17.42
52W Low$8.7

Integra LifeSciences Holdings Corporation (IART) Revenue

Annual & quarterly revenue history · segment & region breakdown

IART · revenue · updated Jun 8, 2026

Core revenue metrics

Integra LifeSciences Holdings Corporation trailing twelve-month (TTM) revenue is $1.64B, an increase of 1.53% year-over-year from $1.64B in FY2025.

TTM revenue
$1.64B
4-quarter sum · USD
YoY growth
+1.53%
vs FY2025 $1.64B
Price / sales
0.81×
mktCap ÷ TTM rev
Revenue per day
$5M
Est. TTM ÷ 365
Revenue / employee
$374K
4396 employees
FY2025
$1.64B
FY2024
$1.61B
5Y CAGR
+1.2%
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Integra LifeSciences Holdings Corporation SEC filings · GAAPUpdated: 2026-06-08

Revenue trend

20252006 · Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
2025-12-31$1.64B+$0.02B+1.53%
2024-12-31$1.61B+$0.07B+4.47%
2023-12-31$1.54B-$0.02B-1.03%
2022-12-31$1.56B+$0.02B+0.99%
2021-12-31$1.54B+$0.17B+12.43%
2020-12-31$1.37B-$0.15B-9.60%
2019-12-31$1.52B+$0.05B+3.06%
2018-12-31$1.47B+$0.28B+23.92%
2017-12-31$1.19B+$0.20B+19.77%
2016-12-31$0.99B+$0.11B+12.39%
IART revenue by year · IART revenue history · IART annual revenue data

Compare revenue vs peers

Medical - Devices

Compare IART revenue against listed peers. Click any row to open that company's revenue tab.

Revenue breakdown

Segment & Geography
By business segment
Total$1.64B
$1.20B73.4%
$0.43B26.6%
By geography
Total$1.64B
$1.20B73.7%
$0.19B11.6%
$0.16B9.9%
$0.08B4.8%
Data from Integra LifeSciences Holdings Corporation annual 10-K filing · FY ending 2025-12-31
IART revenue breakdown · IART revenue by segment · IART revenue by region

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Integra LifeSciences Holdings Corporation receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Integra LifeSciences Holdings Corporation reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Integra LifeSciences Holdings Corporation's 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

IART revenue · 4 questions

IART's trailing twelve-month (TTM) revenue is $1.64B. That is an increase of 1.53% year-over-year from $1.64B in FY2025.

IART revenueIART annual revenuewhat is IART revenueIART TTM revenue

Source: FMP · Integra LifeSciences Holdings Corporation SEC filings · GAAP · Integra LifeSciences Holdings Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026